The integration of artificial intelligence and machine learning technologies is markedly accelerating discovery and development in biotech. Breakthroughs include the creation of AI-driven platforms for antibody specificity characterization, genomic mutation-based cancer classification tools, and AI-powered 3D bioprinting enhancements. These computational methodologies promise to streamline workflows, enable high-throughput screening, and refine diagnostic precision, thereby enhancing translational impact in drug development and personalized medicine.